MP0712, a 212Pb-Radio-DARPin targeting DLL3, as first candidate of Molecular Partners’ RDT platform in development in partnership with Orano Med Positive tumor to kidney ratio and biodistribution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback